ethyl 1-(4-chlorobenzyl)-1H-indole-2-carboxylate | 199604-34-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: ethyl 1-(4-chlorobenzyl)-1H-indole-2-carboxylate
• 英文别名: ethyl N-(4-chlorobenzyl)indole-2-carboxylate；ethyl 1-[(4-chlorophenyl)methyl]indole-2-carboxylate
• CAS: 199604-34-7
• 化学式: C₁₈H₁₆ClNO₂
• 分子量: 313.784
• InChiKey: SNFBFLWZUXLNOB-UHFFFAOYSA-N

物化性质

• 沸点：
  475.6±30.0 °C(Predicted)
• 密度：
  1.20±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  22
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  31.2
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  ethyl 1-(4-chlorobenzyl)-1H-indole-2-carboxylate 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 lithium hydroxide 作用下， 以 四氢呋喃 、 二氯甲烷 、 水 为溶剂， 反应 24.33h， 生成 1-(1-(4-chlorobenzyl)-1H-indole-2-carbonyl)piperidine-4-carboxylic acid
  参考文献：
  名称：

  ARBOVIRUS INHIBITORS AND USES THEREOF

  摘要：

  本发明涉及化学化合物、其发现方法以及其治疗用途。具体而言，本发明提供了作为虫媒病毒抑制剂的化合物。

  公开号：

  US20120252807A1
• 作为产物：
  描述：

  吲哚-2-羧酸 在 氯化亚砜 、 caesium carbonate 作用下， 以 乙腈 为溶剂， 生成 ethyl 1-(4-chlorobenzyl)-1H-indole-2-carboxylate
  参考文献：
  名称：

  Identification of indole scaffold-based dual inhibitors of NOD1 and NOD2

  摘要：

  NOD1 and NOD2 are important members of the pattern recognition receptor family and play a crucial role within the context of innate immunity. However, overactivation of NODs, especially of NOD1, has also been implicated in a number of diseases. Surprisingly, NOD1 remains a virtually unexploited target in this respect. To gain additional insight into the structure-activity relationships of NOD1 inhibitors, a series of novel analogs has been designed and synthesized and then screened for their NOD1-inhibitory activity. Selected compounds were also investigated for their NOD2-inhibitory activity. Two compounds 4 and 15, were identified as potent mixed inhibitors of NOD1 and NOD2, displaying a balanced inhibitory activity on both targets in the low micromolar range. The results obtained have enabled a deeper understanding of the structural requirements for NOD1 and NOD2 inhibition. (C) 2016 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2016.08.044

文献信息

• Monocyte chemoattractant protein-1 inhibitor compounds
  申请人：Zeneca Limited

  公开号：US06441004B1

  公开（公告）日：2002-08-27

  The invention concerns the use of a compound of the formula (I) in which Z, X, T, A, R1, R2, p and q have any of the meanings defined herein, and their pharmaceutically acceptable salts or in vivo hydrolysable esters, in the treatment of a disease or condition mediated by monocyte chemoattractant protein-1 (MCP-1). Certain of the components of formula (I) are novel and are provided, together with pharmaceutical compositions thereof, as further features of the invention.

  该发明涉及在治疗由单核细胞趋化蛋白-1（MCP-1）介导的疾病或症状中使用具有式（I）中Z、X、T、A、R1、R2、p和q中任意一个定义的含义的化合物，以及它们的药学上可接受的盐或体内可水解的酯。式（I）的某些组分是新颖的，并且随着药物组合物一起提供，作为该发明的进一步特征。
• Synthesis of substituted 3-amino-4-cyano-1-oxo-1,2,5,10-tetrahydroazepino [3,4-<i>b</i>]indoles
  作者：Reinhard Troschütz、Annin Hoffmann

  DOI：10.1002/jhet.5570340510

  日期：1997.9

  suitable substituted ethyl 3-formylindole-2-carboxy-latcs 2, condensation with malononitrile (3) and subsequent sodium borohydride-reduction yielded ethyl 3-(2,2-dicyanoethyl)indole-2-carboxylates 5 and 19, respectively, which were cyclized in boiling alkoxides to 3-alkoxy-4-cyanoazepino[3,4-b]indoles 10,11,20 and 21. This sequence constitutes a novel and flexible route to functional azepino[3,4-b>]indoles

  概述了在芳香核和N 10上带有取代基的3-氨基和3-二烷基氨基-4-氰基氮杂环庚烷[3,4-fc]吲哚的制备。从合适的取代的3-甲酰基吲哚-2-羧基-latcs 2开始，与丙二腈（3）缩合，然后硼氢化钠还原，分别得到3-（2,2-二氰乙基）吲哚-2-羧酸乙酯5和19，其在沸腾的醇盐中环化成3-烷氧基-4-氰基氮杂环庚烷[3,4- b ]吲哚10、11、20和21。该序列构成了向功能性azepino [3,4- b >]吲哚的新颖且灵活的途径。10、11、20的氨解用不同的胺和氨水制得的化合物21和21产生标题化合物，并对其可能的生物学活性进行了筛选。
• ARBOVIRUS INHIBITORS AND USES THEREOF
  申请人：Larsen Scott

  公开号：US20120252807A1

  公开（公告）日：2012-10-04

  The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of arboviruses.

  本发明涉及化学化合物、其发现方法以及其治疗用途。具体而言，本发明提供了作为虫媒病毒抑制剂的化合物。
• AMIDE COMPOUND
  申请人：Nozawa Eisuke

  公开号：US20110144153A1

  公开（公告）日：2011-06-16

  [Problems] A compound, which is useful as an active ingredient of a pharmaceutical composition, for example, a pharmaceutical composition for treating chronic renal failure and/or diabetic nephropathy, is provided. [Solving Means] The present inventors have conducted extensive studies on a compound having an EP4 receptor antagonistic activity, and confirmed that the amide compound of the present invention has an EP4 receptor antagonistic activity, thereby completing the present invention. The amide compound of the present invention has an EP4 receptor antagonistic activity, and can be used as an active ingredient of a pharmaceutical composition for preventing and/or treating various EP4-related diseases, for example, chronic renal failure and/or diabetic nephropathy, and the like.

  【问题】提供一种化合物，该化合物可用作药物组合物的活性成分，例如用于治疗慢性肾衰竭和/或糖尿病肾病的药物组合物。 【解决方法】本发明人对具有EP4受体拮抗活性的化合物进行了广泛的研究，并确认本发明的酰胺化合物具有EP4受体拮抗活性，从而完成了本发明。本发明的酰胺化合物具有EP4受体拮抗活性，可用作预防和/或治疗各种EP4相关疾病的药物组合物的活性成分，例如慢性肾衰竭和/或糖尿病肾病等。
• Arbovirus inhibitors and uses thereof
  申请人：Larsen Scott

  公开号：US08846684B2

  公开（公告）日：2014-09-30

  The present invention relates to chemical compounds, methods for their discovery, and their therapeutic use. In particular, the present invention provides compounds as inhibitors of arboviruses.

  本发明涉及化学化合物，其发现方法以及它们的治疗用途。特别是，本发明提供了作为蚊媒病毒抑制剂的化合物。